1-{1H-imidazo[4,5-b]pyridin-2-yl}methanamine dihydrochloride, 95%, 100mg

2-Ethyl-4,5,6,7-tetrahydro-2h-indazol-3-amine, 95+%, 500mg

2,6-Bis(trifluoromethyl)bromobenzene, 98.0%, 10g

6-Methoxy-2-naphthaleneboronic acid, 96.0%, 5g

(5E)-5-[(2-hydroxy-1-naphthyl)methylene]-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

4-PHENYLPYRIMIDINE, 97.0%, 10g

2-Fluoro-4-methylpyridine, 98.0%, 25g

1,4-chloranil, min. 98%, pa, 10 g, glass packaging

1-(4-Chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperidine, 98%, 1g

2,3-Difluoro-N,N-dimethylbenzamide, 95%, 1g

GC capillary column ROTI®Cap-1701, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

5-Hydroxypyrimidine-2-carbonitrile, 97%, 100mg

1-(Perfluorohexyl)octane, 98%, 25g